Down-regulation of brain nuclear factor-kappa B pathway in the cyclooxygenase-2 knockout mouse

Molecular Brain Research

Volumn 139, Issue 2, 2005, Pages 217-224

  Rao, Jagadeesh S ^a   Langenbach, Robert ^b   Bosetti, Francesca ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

COX 2 KO; NF B; p50; p65; Phospho I B ; Phospho p65

Indexed keywords

CYCLOOXYGENASE 2; DNA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; KNOCKOUT MOUSE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; T LYMPHOCYTE; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; BRAIN; CYCLOOXYGENASE 2; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; MICE; MICE, KNOCKOUT; NF-KAPPA B; PROTEIN SUBUNITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 24944461118     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2005.05.008     Document Type: Article

References (50)

1. S.B. Appleby, A. Ristimaki, K. Neilson, K. Narko, and T. Hla Structure of the human cyclo-oxygenase-2 gene J. Biochem. 302 Pt. 3 1994 723 727
2. P.A. Baeuerle, and D. Baltimore Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor Cell 53 1988 211 217
3. F. Bosetti, R. Langenbach, and G.R. Weerasinghe Prostaglandin E2 and microsomal prostaglandin E synthase-2 expression are decreased in the cyclooxygenase-2-deficient mouse brain despite compensatory induction of cyclooxygenase-1 and Ca2+-dependent phospholipase A2 J. Neurochem. 91 2004 1389 1397
4. J.E. Carroll, E.F. Howard, D.C. Hess, C.G. Wakade, Q. Chen, and C. Cheng Nuclear factor-kappa B activation during cerebral reperfusion: effect of attenuation with N-acetylcysteine treatment Brain Res. Mol. Brain Res. 56 1998 186 191
5. K.S. Chun, Y.S. Keum, S.S. Han, Y.S. Song, S.H. Kim, and Y.J. Surh Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation Carcinogenesis 24 2003 1515 1524
6. J.A. Clemens, D.T. Stephenson, E.B. Smalstig, E.P. Dixon, and S.P. Little Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats Stroke 28 1997 1073 1080 (discussion 1080-1081)
7. E.J. Duh, W.J. Maury, T.M. Folks, A.S. Fauci, and A.B. Rabson Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat Proc. Natl. Acad. Sci. U. S. A. 86 1989 5974 5978
8. Z. Feng, D. Li, P.C. Fung, Z. Pei, D.B. Ramsden, and S.L. Ho COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice NeuroReport 14 2003 1927 1929
9. S. Ghelardoni, Y.A. Tomita, J.M. Bell, S.I. Rapoport, and F. Bosetti Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain Biol. Psychiatry 56 2004 248 254
10. S. Ghosh, and M. Karin Missing pieces in the NF-kappaB puzzle Cell 109 2002 S81 S96 (Suppl.)
11. M. Grilli, J.J. Chiu, and M.J. Lenardo NF-kappa B and Rel: participants in a multiform transcriptional regulatory system Int. Rev. Cytol. 143 1993 1 62
12. F.P. Huang, Z.Q. Wang, D.C. Wu, G.P. Schielke, Y. Sun, and G.Y. Yang Early NFkappaB activation is inhibited during focal cerebral ischemia in interleukin-1beta-converting enzyme deficient mice J. Neurosci. Res. 73 2003 698 707
13. C. Iadecola, K. Niwa, S. Nogawa, X. Zhao, M. Nagayama, E. Araki, S. Morham, and M.E. Ross Reduced susceptibility to ischemic brain injury and N-methyl-d-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice Proc. Natl. Acad. Sci. U. S. A. 98 2001 1294 1299
14. M.A. Iniguez, S. Martinez-Martinez, C. Punzon, J.M. Redondo, and M. Fresno An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes J. Biol. Chem. 275 2000 23627 23635
15. Y.J. Jung, J.S. Isaacs, S. Lee, J. Trepel, and L. Neckers IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis FASEB J. 17 2003 2115 2117
16. C. Kaltschmidt, B. Kaltschmidt, H. Neumann, H. Wekerle, and P.A. Baeuerle Constitutive NF-kappa B activity in neurons Mol. Cell. Biol. 14 1994 3981 3992
17. B. Kaltschmidt, R.A. Linker, J. Deng, and C. Kaltschmidt Cyclooxygenase-2 is a neuronal target gene of NF-kappaB BMC Mol. Biol. 3 2002 16
18. T. Kanekura, S. Goorha, K. Kirtikara, and L.R. Ballou The involvement of NF-kappaB in the constitutive overexpression of cyclooxygenase-2 in cyclooxygenase-1 null cells Biochim. Biophys. Acta 1542 2002 14 22
19. C.A. Kassed, and M. Herkenham NF-kappaB p50-deficient mice show reduced anxiety-like behaviors in tests of exploratory drive and anxiety Behav. Brain Res. 154 2004 577 584
20. E.B. Kopp, and S. Ghosh NF-kappa B and rel proteins in innate immunity Adv. Immunol. 58 1995 1 27
21. T. Kosaka, A. Miyata, H. Ihara, S. Hara, T. Sugimoto, O. Takeda, E. Takahashi, and T. Tanabe Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2 Eur. J. Biochem. 221 1994 889 897
22. D.K. Lahiri An region upstream of the gene promoter for the beta-amyloid precursor protein interacts with proteins from nuclear extracts of the human brain and PC12 cells Brain Res. Mol. Brain Res. 58 1998 112 122
23. A. Lilienbaum, and A. Israel From calcium to NF-kappa B signaling pathways in neurons Mol. Cell. Biol. 23 2003 2680 2698
24. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408
25. W.J. Lukiw, and N.G. Bazan Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex J. Neurosci. Res. 53 1998 583 592
26. M.P. Mattson, and S. Camandola NF-kappaB in neuronal plasticity and neurodegenerative disorders J. Clin. Invest. 107 2001 247 254
27. M.K. Meffert, J.M. Chang, B.J. Wiltgen, M.S. Fanselow, and D. Baltimore NF-kappa B functions in synaptic signaling and behavior Nat. Neurosci. 6 2003 1072 1078
28. J.R. Mestre, D.E. Rivadeneira, P.J. Mackrell, M. Duff, P.P. Stapleton, V. Mack-Strong, S. Maddali, G.P. Smyth, T. Tanabe, and J.M. Daly Overlapping CRE and E-box promoter elements can independently regulate COX-2 gene transcription in macrophages FEBS Lett. 496 2001 147 151
29. L. Minghetti Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases J. Neuropathol. Exp. Neurol. 63 2004 901 910
30. S.G. Morham, R. Langenbach, C.D. Loftin, H.F. Tiano, N. Vouloumanos, J.C. Jennette, J.F. Mahler, K.D. Kluckman, A. Ledford, and C.A. Lee Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse Cell 83 1995 473 482
31. S. Nakao, Y. Ogtata, E. Shimizu, M. Yamazaki, S. Furuyama, and H. Sugiya Tumor necrosis factor alpha (TNF-alpha)-induced prostaglandin E2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NFkappaB in human gingival fibroblasts Mol. Cell. Biochem. 238 2002 11 18
32. R. Newton, L.M. Kuitert, M. Bergmann, I.M. Adcock, and P.J. Barnes Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta Biochem. Biophys. Res. Commun. 237 1997 28 32
33. J. Paik, J.Y. Lee, and D. Hwang Signaling pathways for TNFa-induced COX-2 expression: mediation through MAP kinases and NFkB, and inhibition by certain nonsteroidal anti-inflammatory drugs Adv. Exp. Med. Biol. 507 2002 503 508
34. S. Plyte, M. Boncristiano, E. Fattori, F. Galvagni, S.R. Paccani, M.B. Majolini, S. Oliviero, G. Ciliberto, J.L. Telford, and C.T. Baldari Identification and characterization of a novel nuclear factor of activated T-cells-1 isoform expressed in mouse brain J. Biol. Chem. 276 2001 14350 14358
35. B. Poligone, and A.S. Baldwin Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins J. Biol. Chem. 276 2001 38658 38664
36. K.L. Quinlan, S.M. Naik, G. Cannon, C.A. Armstrong, N.W. Bunnett, J.C. Ansel, and S.W. Caughman Substance P activates coincident NF-AT- and NF-kappa B-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization J. Immunol. 163 1999 5656 5665
37. A. Salminen, P.K. Liu, and C.Y. Hsu Alteration of transcription factor binding activities in the ischemic rat brain Biochem. Biophys. Res. Commun. 212 1995 939 944
38. R. Schreck, P. Rieber, and P.A. Baeuerle Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1 EMBO J. 10 1991 2247 2258
39. K. Seibert, J. Masferrer, Y. Zhang, S. Gregory, G. Olson, S. Hauser, K. Leahy, W. Perkins, and P. Isakson Mediation of inflammation by cyclooxygenase-2 Agents Actions Suppl. 46 1995 41 50
40. V.A. Shatrov, V. Lehmann, and S. Chouaib Sphingosine-1-phosphate mobilizes intracellular calcium and activates transcription factor NF-kappa B in U937 cells Biochem. Biophys. Res. Commun. 234 1997 121 124
41. L. Sun, and G. Carpenter Epidermal growth factor activation of NF-kappaB is mediated through IkappaBalpha degradation and intracellular free calcium Oncogene 16 1998 2095 2102
42. I.M. Verma, J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation Genes Dev. 9 1995 2723 2735
43. K. Yamagata, K.I. Andreasson, W.E. Kaufmann, C.A. Barnes, and P.F. Worley Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids Neuron 11 1993 371 386
44. Y. Yamamoto, M.J. Yin, K.M. Lin, and R.B. Gaynor Sulindac inhibits activation of the NF-kappaB pathway J. Biol. Chem. 274 1999 27307 27314
45. K. Yang, X.S. Mu, and R.L. Hayes Increased cortical nuclear factor-kappa B (NF-kappa B) DNA binding activity after traumatic brain injury in rats Neurosci. Lett. 197 1995 101 104
46. M.J. Yin, Y. Yamamoto, and R.B. Gaynor The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta Nature 396 1998 77 80
47. S. Zhang, T. Tobaru, J.A. Zivin, and D.A. Shackelford Activation of nuclear factor-kappaB in the rabbit spinal cord following ischemia and reperfusion Brain Res. Mol. Brain Res. 63 1998 121 132
48. H. Zhong, R.E. Voll, and S. Ghosh Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300 Mol. Cell 1 1998 661 671
49. H. Zhong, M.J. May, E. Jimi, and S. Ghosh The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1 Mol. Cell 9 2002 625 636
50. M.A. Zimmerman, C.H. Selzman, L.L. Reznikov, S.A. Miller, C.D. Raeburn, J. Emmick, X. Meng, and A.H. Harken Lack of TNF-alpha attenuates intimal hyperplasia after mouse carotid artery injury Am. J. Physiol.: Regul., Integr. Comp. Physiol. 283 2002 R505 R512